Target intelligence / Profile preview

Extracellular melanin

Molecular classification
Biopolymer, Pigment, Other
01

Overview

Extracellular melanin is a complex biopolymer located outside the cell cytoplasm, primarily found within the cell walls of melanized pathogenic fungi or released into the extracellular environment during tissue damage and malignancy. In fungal pathogens such as Cryptococcus neoformans, melanin serves as a potent virulence factor that shields the organism from host immune defenses, including phagocytosis and oxidative bursts, while also providing resistance to various antifungal agents (Eisenman & Casadevall, 2012, PMID: 22461443). In oncology, particularly melanoma, extracellular melanin represents a unique antigenic target because it is often accessible to the systemic circulation due to the disorganized nature of tumor vasculature and cell death (Dadachova et al., 2004, PMID: 15319400). Therapeutic approaches have focused on using monoclonal antibodies, such as 18B7 or 6D2, to bind this pigment and deliver cytotoxic radionuclides directly to the site of infection or tumor (Nosanchuk & Casadevall, 2003, PMID: 12855493). While this strategy offers a novel way to treat resistant infections and metastatic melanoma, the ubiquitous presence of melanin in healthy tissues like the skin and eyes poses a significant risk for off-target toxicity. Furthermore, the release of neuromelanin into the extracellular space in the brain is associated with pro-inflammatory responses in neurodegenerative conditions like Parkinson's disease, making its clearance a potential therapeutic goal (Zhang et al., 2011, PMID: 21415394).

Other names
Fungal melaninCell wall melaninNeuromelanin (extracellular)EumelaninPheomelanin
02

Mechanism of action

Targeted delivery of radionuclides via radio-immunotherapy (RIT) or antibody-mediated opsonization and growth inhibition.

03

Biological functions

Virulence factorPhotoprotectionAntioxidantMetal ion sequestrationStructural integrity
04

Disease associations

InfectionCancerNeurodegenerative disease
05

Safety considerations

Off-target toxicity to healthy melanocytes in the skinPotential damage to the retinal pigment epithelium in the eyeNeurotoxicity due to targeting neuromelanin in the substantia nigraSequestration of drugs in melanin-rich tissues (melanin sink effect)
06

Interacting drugs

18B7 monoclonal antibody

2 more in the full profile.

07

Biomarkers

Melanin-positive circulating tumor cellsMelanin concentration in cerebrospinal fluidMelanuria

Beyond the preview

Go deeper on Extracellular melanin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular melanin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call